Luis Sanchez-Perez

Luis Sanchez-Perez

Duke University

H-index: 40

North America-United States

About Luis Sanchez-Perez

Luis Sanchez-Perez, With an exceptional h-index of 40 and a recent h-index of 31 (since 2020), a distinguished researcher at Duke University, specializes in the field of Gene Therapy/Immune Oncology.

His recent articles reflect a diverse array of research interests and contributions to the field:

Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models

IL7 and IL7 Flt3L co-expressing CAR T cells improve therapeutic efficacy in mouse EGFRvIII heterogeneous glioblastoma

Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice

The minority scientists’ experience: challenging and overcoming barriers to enhancing diversity and career advancement

Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma

Multiepitope supramolecular peptide nanofibers eliciting coordinated humoral and cellular antitumor immune responses

A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope

Oncolytic virus-derived type I interferon restricts CAR T cell therapy

Luis Sanchez-Perez Information

University

Position

Assistant Professor of Neurosurgery

Citations(all)

6880

Citations(since 2020)

3857

Cited By

4523

hIndex(all)

40

hIndex(since 2020)

31

i10Index(all)

61

i10Index(since 2020)

51

Email

University Profile Page

Google Scholar

Luis Sanchez-Perez Skills & Research Interests

Gene Therapy/Immune Oncology

Top articles of Luis Sanchez-Perez

Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models

Science translational medicine

2023/2/8

Scott Parker
Scott Parker

H-Index: 12

Luis Sanchez-Perez
Luis Sanchez-Perez

H-Index: 27

IL7 and IL7 Flt3L co-expressing CAR T cells improve therapeutic efficacy in mouse EGFRvIII heterogeneous glioblastoma

Frontiers in Immunology

2023/2/3

Oncolytic virus–mediated expansion of dual-specific CAR T cells improves efficacy against solid tumors in mice

Science translational medicine

2022/4/13

The minority scientists’ experience: challenging and overcoming barriers to enhancing diversity and career advancement

The Journal of Immunology

2022/1/15

Luis Sanchez-Perez
Luis Sanchez-Perez

H-Index: 27

Neuronal CaMKK2 promotes immunosuppression and checkpoint blockade resistance in glioblastoma

Nature Communications

2022/10/29

Multiepitope supramolecular peptide nanofibers eliciting coordinated humoral and cellular antitumor immune responses

Science Advances

2022/7/20

Yaoying Wu
Yaoying Wu

H-Index: 10

Luis Sanchez-Perez
Luis Sanchez-Perez

H-Index: 27

A conjoined universal helper epitope can unveil antitumor effects of a neoantigen vaccine targeting an MHC class I-restricted neoepitope

npj Vaccines

2021/1/18

Oncolytic virus-derived type I interferon restricts CAR T cell therapy

Nature communications

2020/6/24

CAR T cells and checkpoint inhibition for the treatment of glioblastoma

2020/6/2

Luis Sanchez-Perez
Luis Sanchez-Perez

H-Index: 27

4-1BB agonism averts TIL exhaustion and licenses PD-1 blockade in glioblastoma and other intracranial cancers

Clinical Cancer Research

2020/3/15

Daniel Wilkinson
Daniel Wilkinson

H-Index: 1

Luis Sanchez-Perez
Luis Sanchez-Perez

H-Index: 27

Targeting PD-L1 initiates effective antitumor immunity in a murine model of Cushing disease

Clinical Cancer Research

2020/3/1

Luis Sanchez-Perez
Luis Sanchez-Perez

H-Index: 27

Patrick Healy
Patrick Healy

H-Index: 6

Comparative study of α-helical and β-sheet self-assembled peptide nanofiber vaccine platforms: influence of integrated T-cell epitopes

Biomaterials science

2020

Yaoying Wu
Yaoying Wu

H-Index: 10

Luis Sanchez-Perez
Luis Sanchez-Perez

H-Index: 27

First in human dose calculation of a single-chain bispecific antibody targeting glioma using the MABEL approach

Journal for Immunotherapy of Cancer

2020

Luis Sanchez-Perez
Luis Sanchez-Perez

H-Index: 27

See List of Professors in Luis Sanchez-Perez University(Duke University)